Management of Baroreceptor Orthostatic Hypotension in Elderly Patients
Diagnosis and Assessment
- The European Heart Journal recommends orthostatic hypotension testing by measuring BP after 5 minutes of rest in sitting or lying position, followed by measurements at 1 and/or 3 minutes after standing, before starting or intensifying any blood pressure-lowering medication 1, 3
- Orthostatic hypotension is defined as a decrease in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg within 3 minutes of standing, according to Praxis Medical Insights 3
- Assessment should include evaluation of symptoms such as dizziness, lightheadedness, and cognitive impairment that may indicate baroreceptor dysfunction, as recommended by the European Heart Journal 2
Pharmacological Management
- Droxidopa is FDA-approved for neurogenic orthostatic hypotension, as stated in Diabetes Care 4
Special Considerations for Elderly Patients
- The European Heart Journal recommends that when initiating treatment for patients aged ≥85 years and/or with moderate-to-severe frailty, long-acting dihydropyridine CCBs or RAS inhibitors should be considered as first-line agents for hypertension management, followed by low-dose diuretics if necessary 5
- For patients with both orthostatic hypotension and supine hypertension, the European Heart Journal recommends switching BP-lowering medications that worsen orthostatic hypotension to alternative therapies rather than simply reducing dosage 1
- The European Heart Journal advises avoiding beta-blockers and alpha-blockers in frail elderly patients unless specifically indicated 5